Researchers have developed a novel compound that could transform the way we treat Alzheimer's disease, offering not just a ...

Chimeric antigen receptor T-cell therapy—CAR T for short—has been a major advance in treating blood cancers like leukemia and ...

Scientists at the Buck Institute for Research on Aging have shown that an orally administered small molecule, ...

A key cancer-fighting gene in leukemia is switched off—not broken—and scientists from The Jackson Laboratory (JAX) have found ...

Revealing the limitations of cloning, researchers who repeatedly cloned mice for two decades have discovered that such serial duplication triggers grave genetic mutations that accumulate ​over the ...

For two decades, a team of researchers cloned mice from successive generations of clones until the new clones were no longer ...

Scientists at the Buck Institute for Research on Aging have shown that an orally administered small molecule, N-propargylglycine (N-PPG), can ...

A key cancer-fighting gene in leukemia is switched off—not broken—and scientists from The Jackson Laboratory (JAX) found a way to switch it back on.In ...

A new CAR T-cell therapy attacks supportive cells in the tumor microenvironment that bear the surface protein, uPAR.

Researchers have built a dissolvable skin patch loaded with a ginger-derived compound and a light-absorbing dye that, when ...

Using a custom AI system, researchers identified chemical compounds that show early promise against two conditions that lack effective treatments: hepatocellular carcinoma, the most aggressive form of ...

Stanford researchers have cured type 1 diabetes in mice by resetting their immune systems with a two-step transplant strategy ...